
IDSA Issues COVID Vaccine Guidelines for Immunocompromised Individuals
The IDSA has issued new guidelines recommending that immunocompromised individuals, including children and adults, receive an age-appropriate COVID-19 vaccine dose promptly for the upcoming respiratory virus season, emphasizing the importance of vaccination for their protection and encouraging close contacts to stay current with vaccines. The guidelines are based on recent evidence showing that vaccination reduces hospitalization, severe illness, and death among immunocompromised people, with recommendations for flexible timing and dosing based on individual circumstances.












